| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $139.3M | — | +10.4% |
| Cost of Revenue | $75.7M | — | +7.4% |
| Gross Profit | $63.6M | — | +14.2% |
| R&D Expense | $10.5M | — | -0.7% |
| SG&A Expense | $17.0M | — | +1.0% |
| Operating Income | $9.8M | — | +117.1% |
| Pre-tax Income | $11.3M | — | +89.1% |
| Income Tax | $3.2M | — | +34.4% |
| Net Income | $8.1M | — | +125.4% |
| EPS (Basic) | $0.34 | — | +126.7% |
| EPS (Diluted) | $0.33 | — | +120.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $124.0M | +11.9% | +49.9% |
| Short-term Investments | $12.3M | -28.8% | -13.0% |
| Accounts Receivable | $85.6M | +8.3% | +15.8% |
| Inventory | $14.9M | +3.3% | +12.6% |
| Current Assets | $248.6M | +6.4% | +27.9% |
| Total Assets | $778.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.5M | — | -4.6% |
| Capital Expenditures | $3.5M | — | +180.5% |
| Investing Cash Flow | -$4.8M | — | -63.9% |
| Financing Cash Flow | $658K | — | +103.0% |
| Free Cash Flow | $14.0M | — | -18.2% |
| +5.6% |
| Current Liabilities | $70.7M | +5.6% | +13.9% |
| Total Liabilities | $95.4M | +6.7% | +18.3% |
| Stockholders' Equity | $683.1M | +1.4% | +4.0% |